Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O W Akkerman

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2018
Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort studyI S Pradipta, N Van't Boveneind-Vrubleuskaya, O W Akkerman, et al.
IJTLD Open|September 17, 2025
TB treatment support strategies for children, adolescents, and young adults in a low-incidence settingA R Verhage, A C Hesseling, G H Koppelman, et al.
Expert Review of Clinical Pharmacology|June 21, 2016
Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosisT V A Nguyen, T B T Cao, O W Akkerman, et al.
International Journal of Antimicrobial Agents|June 25, 2024
Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration studyK Longman, O W Akkerman, S Ghimire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trialsM S Bolhuis, O W Akkerman, M G G Sturkenboom, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2017
Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An updateM A G M Kroon, A M Akkerman-Nijland, B L Rottier, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 27, 2024
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugsM Cevik, A Sturdy, A E Maraolo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 11, 2020
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic reviewR A Chimeh, F Gafar, I S Pradipta, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2015
Breakpoints and drug exposure are inevitably closely linkedJ W C Alffenaar, O W Akkerman, M S Bolhuis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Isoniazid and rifampicin exposure during treatment in drug-susceptible TBO W Akkerman, R D C Dijkwel, H A M Kerstjens, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2018
Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort studyI S Pradipta, N Van't Boveneind-Vrubleuskaya, O W Akkerman, et al.
IJTLD Open|September 17, 2025
TB treatment support strategies for children, adolescents, and young adults in a low-incidence settingA R Verhage, A C Hesseling, G H Koppelman, et al.
Expert Review of Clinical Pharmacology|June 21, 2016
Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosisT V A Nguyen, T B T Cao, O W Akkerman, et al.
International Journal of Antimicrobial Agents|June 25, 2024
Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration studyK Longman, O W Akkerman, S Ghimire, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trialsM S Bolhuis, O W Akkerman, M G G Sturkenboom, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2017
Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis - An updateM A G M Kroon, A M Akkerman-Nijland, B L Rottier, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 27, 2024
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugsM Cevik, A Sturdy, A E Maraolo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 11, 2020
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic reviewR A Chimeh, F Gafar, I S Pradipta, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2015
Breakpoints and drug exposure are inevitably closely linkedJ W C Alffenaar, O W Akkerman, M S Bolhuis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 26, 2023
Isoniazid and rifampicin exposure during treatment in drug-susceptible TBO W Akkerman, R D C Dijkwel, H A M Kerstjens, et al.
Pageof 4